$ALNY

$227.66 +$3.63 (1.62%) Close

$ALNY Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$ALNY Management Team

Dr. Kevin Fitzgerald

Executive Vice President

Chief Scientific Officer

Head - Early Research and Early Development

Age 57

Compensation $2.673M USD

Sex Male

Mr. Robert Hesslein

Executive Vice President

Chief Legal Officer

Secretary

Age 71

Compensation -

Sex Male

Dr. Pushkal Garg

Executive Vice President

Chief Research and Development Officer

Age 57

Compensation $2.919M USD

Sex Male

Ms. Amy Schulman

Independent Chairman of the Board

Age 64

Compensation $558.8K USD

Sex Female

Dr. Yvonne Greenstreet

Chief Executive Officer

Director

Age 62

Compensation $11.49M USD

Sex Female

Mr. Jeffrey Poulton

Chief Financial Officer

Executive Vice President

Age 57

Compensation $3.793M USD

Sex Male

Mr. Tolga Tanguler

Chief Commercial Officer

Age 52

Compensation $2.755M USD

Sex Male

Name / Title	Age	Compensation	Sex
Dr. Kevin Fitzgerald Executive Vice President Chief Scientific Officer Head - Early Research and Early Development	57	$2.673M USD	Male
Mr. Robert Hesslein Executive Vice President Chief Legal Officer Secretary	71	-	Male
Dr. Pushkal Garg Executive Vice President Chief Research and Development Officer	57	$2.919M USD	Male
Ms. Amy Schulman Independent Chairman of the Board	64	$558.8K USD	Female
Dr. Yvonne Greenstreet Chief Executive Officer Director	62	$11.49M USD	Female
Mr. Jeffrey Poulton Chief Financial Officer Executive Vice President	57	$3.793M USD	Male
Mr. Tolga Tanguler Chief Commercial Officer	52	$2.755M USD	Male

Board of Directors

From the proxy statement filed Apr 6, 2026

Directors

serving now

Independent

7 of 8

stated in the proxy; 1 not stated

Average tenure

7.8 years

from year joined

CEO also chairs the board

Amy W. Schulman

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Yvonne L. Greenstreet, M.D. CEO	63	2021 5 years	Not independent	None stated	None stated	Paid as CEO
Elliott Sigal, M.D., Ph.D.	74	2022 4 years	Independent	People, Culture and Compensation Committee Science and Technology Committee · Chair	Vir Biotechnology, Inc.	$486,310
Dennis A. Ausiello, M.D.	80	2012 14 years	Independent	Nominating and Corporate Governance Committee Science and Technology Committee	Seres Therapeutics, Inc., Rani Therapeutics Holdings, Inc.	$479,850
Olivier Brandicourt, M.D.	70	2020 6 years	Independent	People, Culture and Compensation Committee Audit Committee	BeOne Medicines Ltd., Vaxcyte, Inc.	$482,350
Peter N. Kellogg	69	2023 3 years	Independent	Audit Committee · Chair	None stated	$484,850
David E.I. Pyott	72	2015 11 years	Independent	Nominating and Corporate Governance Committee · Chair	Pliant Therapeutics, Inc., Tarsus Pharmaceuticals	$479,850
Margaret A. Hamburg, M.D.	70	2019 7 years	Independent	Nominating and Corporate Governance Committee	None stated	$469,850
Colleen F. Reitan	66	2018 8 years	Independent	Audit Committee People, Culture and Compensation Committee · Chair	Myriad Genetics, Inc.	$492,350
Amy W. Schulman Board chair	65	2014 12 years	Not stated	People, Culture and Compensation Committee Nominating and Corporate Governance Committee	Elevance Health	$541,310

Nominated to join at the meeting

Not on the board yet; they join only if elected.

Stuart A. Arbuckle · 60

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 6, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$ALNY Management Team

Dr. Kevin Fitzgerald

Mr. Robert Hesslein

Dr. Pushkal Garg

Ms. Amy Schulman

Dr. Yvonne Greenstreet

Mr. Jeffrey Poulton

Mr. Tolga Tanguler

Board of Directors

Related-party transactions

No related-party transactions disclosed